Projo Biz Blog

Rite Aid has no defense for cold remedy ads, FTC rules

2:36 PM Mon, Jul 13, 2009 |
By Paul Grimaldi    Email this author |   Email this entry

Drugstore chain Rite Aid Corp. (RAD:NYSE) has agreed to pay $500,000 to settle FTC charges that it used deceptive advertising to sell its Germ Defense medicine -- tablets and lozenges the Pennsylvania company claimed could prevent and treat colds and the flu, according the Federal Trade Commission.

The FTC said Monday that it also reached a settlement with Improvita, which made Germ Defense products for Rite Aid and other stores, as well as sold them on its own Web site.

The settlement with Rite Aid requires the chain to pay $500,000 in consumer refunds and requires the company to change advertising for the medicine.

social bookmarking


Leave a comment





Type the characters you see in the picture above.